International Prostate Cancer Symposium – IPCS
Join the International Prostate Cancer Symposium (IPCS) 2026, a focused gathering of global experts exploring next-generation treatments for prostate cancer. This event bridges research, clinical practice, and industry to address challenges in advanced and resistant disease stages.
| Venue | Palazzo dei Congressi |
|---|---|
| Location | Lugano, Italy |
The IPCS 2026 brings together researchers, clinicians, and industry leaders to discuss cutting-edge therapies—from precision medicine and immunotherapy to theranostics and antibody-drug conjugates. Held before the Advanced Prostate Cancer Consensus Conference (APCCC), it offers a platform for in-depth dialogue on emerging treatments and their potential to reshape clinical guidelines.
Designed to foster collaboration, IPCS 2026 encourages cross-sector exchange and strategic networking. Participants will debate the clinical value and feasibility of innovative approaches, aiming to accelerate their transition from research to real-world patient care. The symposium is a unique opportunity to engage with pioneers driving the future of prostate cancer treatment.
Contact our organiser
Email: info@apccc.org